Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Join the Next Science Investor Hub to interact with our announcements and updates, have your questions answered, and receive ASX Announcements and Company Updates to your inbox. Click here to sign up to the Next Science Investor Hub.

Share Price Performance

Current share price (ASX: NXS)
0.42 -0.02
Updated 4:00PM 26/09/2023
Currency AUD
Change (%) -0.02 (-4.6%)
Volume 394,466
Today's Open 0.43
Intraday High 0.43
Intraday Low 0.41

Historical Share Price

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 8607 5124
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474